A, RT-qPCR of ROR1 mRNA expression in B-CLL cells and a panel of human and rhesus macaque tissues. A, RT-qPCR of ROR1 mRNA expression in B-CLL cells and.

Slides:

Advertisements

Similar presentations

Glioma-derived soluble factor(s) enhance IL-10 signaling.

Advertisements

SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection by.

IFN-γ and STAT1 are required for efficient induction of CXC chemokine receptor 3 (CXCR3) on CD4+ but not CD8+ T cells by Joseph Barbi, Steve Oghumu, Claudio.

Melanoma donor (MD) NK cells are functionally impaired/exhausted.

Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway by Kevin M. Elias, Arian Laurence,

by Norman Nausch, Ioanna E

Uptake of T-MPs for DC maturation and antigen presentation.

Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors by Clemens-Martin Wendtner, David.

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells by Elke Scandella, Ying Men, Silke Gillessen,

Volume 9, Issue 4, Pages (October 1998)

Expression and regulation of MD-2s.

IL-6 is dispensable for the suppressive activity of MDSC on primary CD4+ T-cell activation. IL-6 is dispensable for the suppressive activity of MDSC on.

Suppressive effect of CD39+CD73+ melanoma cells on T-cell proliferation, and reversion of this effect via treatment with the CD39-blocking antibody, CD39.

Functions of myeloid cells.

Maturation, Ag presentation capacity, and IL-12 production of DCs

Caspase-1 from myeloid cells induces tumor proliferation via MyD88 oncogenic signaling. Caspase-1 from myeloid cells induces tumor proliferation via MyD88.

Volume 12, Issue 4, Pages (April 2013)

IL-2–inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells Arun K. Kannan, MS, Nisebita.

Volume 24, Issue 6, Pages (June 2016)

Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen- Specific Regulatory T Cells Dan Blat, Ehud Zigmond, Zoya Alteber,

by Derek Hoi-Hang Ho, and Roger Hoi-Fung Wong

Volume 17, Issue 2, Pages (February 2009)

Serial vaccination with 32Dp210-derived whole cell vaccines in non-tumor-bearing mice stimulates robust antileukemic cytolytic activity. Serial vaccination.

IL-6 neutralization decreases T cell proliferation and cytokine production upon restimulation by allogeneic HUVEC. CIITA transduced HUVECs were cocultured.

Effect of CD4+ Th1 cytokines and HER2-targeted antibodies on MHC class I restoration and HER2369–377-CD8+ T-cell targeting of HER2-expressing cancer cells.

PD-1 blockade enhances T-cell function.

Fig. 1. PARN is differentially expressed in breast cancer versus non-cancerous tissue/cells. PARN is differentially expressed in breast cancer versus non-cancerous.

CHL cell lines induce a suppressive Treg phenotype in cocultured CD4+ T cells. cHL cell lines induce a suppressive Treg phenotype in cocultured CD4+ T.

PTX in combination with PLX397 induces antitumor T-cell response.

Blood Tfr cells do not show specialized humoral regulatory capacity.

Functional characterization of CD4+ T-cells with various antigen specificities after transduction with FoxP3. Functional characterization of CD4+ T-cells.

Functional analysis of CAR-redirected primary NK cells.

Inhibition of lung cancer cell proliferation and viability by CYT387.

M-MDSC:mast cell cross-talk in the regulation of TNFα production.

Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.

KIR-CARs/Dap12 trigger robust antigen-specific cytotoxicity in vitro.

Colony-forming capacity of CD34+ cells with and without CLL-1 expression. Colony-forming capacity of CD34+ cells with and without CLL-1 expression. CD34+

IL6 mRNA is not detected in metastatic prostate cancer cells.

Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection by Maria Moeller, Nicole M. Haynes, Michael.

Anti-CD20 CAR mRNA enhances exPBNK in vitro cytolytic activity against CD20+ B-NHL cells and rituximab-resistant cells. exPBNK were electroporated in the.

Kinetic of NFAT-CBR expression.

pDCs from the melanoma environment responded to TLR-L stimulation.

SAF-1 expression in clinical breast cancer tissues.

Microarray analysis of global gene expression profiles of PC-3 and derivative cell lines. Microarray analysis of global gene expression profiles of PC-3.

ALT-803 stimulates proliferation and activation of human NK cells and T cells in vitro. ALT-803 stimulates proliferation and activation of human NK cells.

Canonical but not adaptive NK-cell function is suppressed by Tregs.

Inactivation of human TRAC and CD52 genes by TALENs

IL1R8 is downmodulated in human lymphoma cell lines.

Neurotensin and insulin induce increases in CTGF, CYR61, and CXCL5 gene expression and stimulate cell proliferation and colony via YAP/TAZ in PDAC cells.

Pirh2 represses p73-dependent transactivation.

CD19-CAR-T cells with short and long spacers show specific in vitro function. CD19-CAR-T cells with short and long spacers show specific in vitro function.

Tregs preferentially regulate TH2 cytokines in skin.

Reduced klotho expression in pancreatic cancer.

DAC treatment alters immune cell composition and enhances cytokine production in the peritoneal lavage. DAC treatment alters immune cell composition and.

Osteoactivin expression is required for the invasive phenotype of in vivo selected bone metastatic 4T1 breast cancer cells. Osteoactivin expression is.

Anti-CD40 activates TAMs and recruits inflammatory monocytes.

Expression of IFN-λs, IFN-λR1, and IL-10R2 in Xenopus tissues after stimulation in vivo with poly(I:C). Expression of IFN-λs, IFN-λR1, and IL-10R2 in Xenopus.

Decreased dopamine uptake following downregulation of SLC6A3.

T cells with a ROR1-specific CAR eliminate tumor cells in vivo only with a modified long spacer. T cells with a ROR1-specific CAR eliminate tumor cells.

Ibrutinib decreases ofatumumab-mediated complement-dependent cytotoxicity. Ibrutinib decreases ofatumumab-mediated complement-dependent cytotoxicity. A,

Flow cytometric gating strategy used to identify CD69 surface expression on CD4 (left paired columns) and CD8 (right paired columns) T lymphocytes. Flow.

p53β regulates cellular senescence.

LDL cholesterol inhibits Vγ9Vδ2 T-cell activation and cytokine production. LDL cholesterol inhibits Vγ9Vδ2 T-cell activation and cytokine production. Preexpanded.

Increased tumorigenic activities of TIM-3–expressing RCC cells.

The effect of βAR signaling on the generation of a cytotoxic CD8+ T-cell response in vivo. The effect of βAR signaling on the generation of a cytotoxic.

Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.

EC-derived SP cells are targeted by CD30.CAR T cells.

Varying the MHC-I affinity, TCR affinity or antigen dose alters the phenotype of CD8 T cells ex vivo. Varying the MHC-I affinity, TCR affinity or antigen.

IL-2–inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells Arun K. Kannan, MS, Nisebita.

Trametinib and combination decrease T-lymphocyte proliferation.

Presentation transcript:

A, RT-qPCR of ROR1 mRNA expression in B-CLL cells and a panel of human and rhesus macaque tissues. A, RT-qPCR of ROR1 mRNA expression in B-CLL cells and a panel of human and rhesus macaque tissues. ROR1 expression was normalized to the geometric mean of the housekeeping genes GAPDH and TBP. B-CLL sample #1 was used as the reference control (ROR1 expression = 1). B, cytolytic activity of rhesus T cells modified to express a R12-ROR1 CAR with human (hu) or rhesus macaque (rh) 4-1BB and CD3ζ domains against 51Cr-labeled K562/ROR1 or K562 cells. Results (mean, SEM) are from three independent experiments in 3 animals (A11047, A13011, and A13002). C, flow cytometric analysis of purity and phenotype of ROR1 CAR-modified CD4+ and CD8+ T cells showing expression of tCD19 in CD4+ (top) or CD8+ (bottom) T cells either mock-transduced, after transduction with the ROR1 CAR (preselection), after selection for tCD19 expression (postselection 1), and after selection for CD4+ or CD8+ cells, respectively (postselection 2). All samples are gated on CD3+ cells. D, cytolytic activity of CD4+ and CD8+ ROR1 CAR-T cells against 51Cr-labeled K562/ROR1 or K562 cells. E, proliferation of CFSE-labeled ROR1 CAR-T cells 72 hours after stimulation with K562/ROR1 cells or unmodified K562 cells. CFSE-dye dilution is shown after gating on CD3+CD4+tCD19+ or CD3+CD8+tCD19+ T cells. F, Luminex cytokine assay of supernatants obtained after 24 hours from triplicate cocultures of 5 × 104 CD4+ or CD8+ ROR1 CAR-T cells with K562/ROR1 cells or media alone as described in Materials and Methods. The asterisk (*) denotes cytokine levels below detection level. Cytokine levels in media controls were below detection level. Data in C to F are shown for macaque A13002 and are representative of results in 3 animals. Carolina Berger et al. Cancer Immunol Res 2015;3:206-216 ©2015 by American Association for Cancer Research